Brief: India's IOL Chemicals & Pharma March-Quarter Profit Falls

IOL Chemicals and Pharmaceuticals

04/06/2021 15:31

June 4 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd
 IOLC.NS :
    * MARCH-QUARTER PROFIT 752.5 MILLION RUPEES VERSUS PROFIT
902.6
MILLION RUPEES YEAR AGO
    * MARCH-QUARTER REVENUE FROM OPERATIONS 4.60 BILLION RUPEES
VERSUS
4.41 BILLION RUPEES YEAR AGO
    * RECOMMENDED FINAL DIVIDEND OF 2 RUPEES/SHARE
    * APPROVED ENHANCEMENT OF ETHYL ACETATE MANUFACTURING
CAPACITY TO
100,000 MT PER ANNUM AT AGGREGATE CAPEX OF 2.5 MILLION RUPEES
    * APPROVED SETTING UP MANUFACTURING FACILITIES FOR IBUPROFEN
DERIVATIVES WITH CAPEX OF 212.6 MILLION RUPEES
    * APPROVED SETTING UP OF NEW MANUFACTURING FACILITY FOR
GABAPENTIN
WITH CAPACITY OF 612 MT/ANNUM WITH CAPEX OF 608.2 MILLION RUPEES
    * APPROVED SETTING UP OF NEW MANUFACTURING FACILITY FOR
MULTIPLE
PHARMA PRODUCTS, WITH  AGGREGATE CAPEX OF ABOUT 900 MILLION
RUPEES

Further company coverage:  IOLC.NS 

 ((Reuters.Briefs@thomsonreuters.com;))